Melanie Shulman

机构：Biogen (United States) · ORCID：0009-0002-5550-9077

发表论文 59 篇 · 总被引 5619 次 · h-index 23

代表论文

• Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment (2023 · Proceedings of the National Academy of Sciences · 被引 130)
• Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease (2023 · JAMA Neurology · 被引 110)
• Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease (2023 · JAMA Neurology · 被引 91)
• TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease (2023 · Nature Aging · 被引 88)
• Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021 · Translational Psychiatry · 被引 70)
• Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis (2023 · Brain · 被引 55)